EFFICACY OF FIRST AVAILABLE DIRECT-ACTING ANTIVIRAL AGENT IN TREATMENT OF CHRONIC HEPATITIS C; RESULTS FROM A SINGLE CENTRE IN PAKISTAN

EFFICACY OF FIRST AVAILABLE DIRECT-ACTING ANTIVIRAL AGENT IN TREATMENT OF CHRONIC HEPATITIS C; RESULTS FROM A SINGLE CENTRE IN PAKISTAN

Objective: To determine the efficacy of dual (sofosbuvir and ribavirin) and triple therapy (sofosbuvir ribavirinpegylated interferon) for treatment of hepatitis C. Study Design: Comparative cross sectional study. Place and Duration of Study: Department of Medicine, Combined Military Hospital, Lahore...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pakistan Armed Forces medical journal 2020-12, Vol.70 (6), p.1885-91
Hauptverfasser: Khan, Arif Qayyum, Mansoor, Hala, Raja, Javed Iqbal, Shahbaz, Raja Yasser, Fida, Samina, Siddique, Muhammad
Format: Artikel
Sprache:eng
Schlagworte:
Antiviral drugs
Drug therapy
Genotype & phenotype
Hepatitis B
Hepatitis C
Hepatitis C virus
hepatitis c virus (hcv)
Infections
Interferon
Liver diseases
Patients
Standard deviation
svr 12
Viral infections
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: To determine the efficacy of dual (sofosbuvir and ribavirin) and triple therapy (sofosbuvir ribavirinpegylated interferon) for treatment of hepatitis C. Study Design: Comparative cross sectional study. Place and Duration of Study: Department of Medicine, Combined Military Hospital, Lahore, from Nov 2014 toMar 2017. Methodology: A total of 182 consecutive patients with age ≥18 years and positive HCV RNA by polymerasechain reaction were included, while patients with haemoglobin of
ISSN:0030-9648
2411-8842
DOI:10.51253/pafmj.v70i6.3469